The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. With more than 300 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise. Its aim is to make the UK the most compelling and logical choice for UK and international partners to develop and commercialise these advanced therapies.
The Cell and Gene Therapy Catapult vision is for the UK to be a global leader in the development, delivery and commercialisation of cell and gene therapy. Where businesses can start, grow and confidently develop advanced therapies, delivering them to patients rapidly, efficiently and effectively.
Our mission is to grow the industry in the UK to substantial and sustainable levels by:
- Accelerating commercialisation of innovation from research
- Complementing industry and academia with unique technical facilities and expertise
- Innovating through collaborations with academic and industry networks
- Facilitating growth of the UK ecosystem by working with industry, the research base, Government, the NHS, industry associations and international organisations